Inspired by the Upcoming CNN Special Report, Weed: Pot Vs. Pills, by Dr. Sanjay Gupta, Cannabis Science Announces its ‘Cannabis Science to End Opioid Deaths Campaign’
April 27, 2018 10:49 ET
|
Cannabis Science, Inc.
IRVINE, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and its partner, Cali RX, are...
Cannabis Science Issues First 2018 Guidance Report; 4/20 Court Date Set For Lawsuit Against San Joaquin County; Revenue Growth Through Acquisitions, Wholesale, and Retail Sales Channels All Multiply
April 10, 2018 07:51 ET
|
Cannabis Science, Inc.
IRVINE, CA, April 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to issue a 2018 First...
Crown Baus Announces Acquisition of Cannabia, the World's First Cannabis Alcoholic Beverage; Will Partner With Cannabis Science to Distribute Non-Alcoholic Versions in the United States and Canada
March 13, 2018 12:48 ET
|
Crown Baus Capital Corp.
BEVERLY HILLS, CA, March 13, 2018 (GLOBE NEWSWIRE) -- Crown Baus Capital Corporation (OTC: CBCA), a global acquisition-based conglomerate, is pleased to announce the Company has acquired a 100%...
Cannabis Science Integrates iCannabinoid Into Pharmacy Openings, While Building, Product Manufacturing, Packaging & Cultivation Procedures are Pending CBIS and City Approvals
March 05, 2018 09:23 ET
|
Cannabis Science, Inc.
Grand Opening of First CBIS Pharmacies Expected Soon IRVINE, CA, March 05, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of...
Cannabis Science Groundbreaking Cancer Research Skyrockets With More Views Than 95% of All Frontiers Articles; Research Team Begins Evaluating Commercialization Options
February 22, 2018 07:39 ET
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is very pleased to report the...
Cannabis Science Announces an Overwhelming Response to its Groundbreaking Research on the Use of Cannabinoids in the Treatment of Cancers, Already Has More Views Than 91% of the Papers Published in all Frontiers Journals
January 18, 2018 08:23 ET
|
Cannabis Science, Inc.
IRVINE, CA, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to report very strong...
Cannabis Science Announces its Construction Project Management (CPMT) Teams in Support of the Company’s Initiative to Establish Pharmacies and Medical Centers in California and Throughout the U.S.
January 10, 2018 13:08 ET
|
Cannabis Science, Inc.
IRVINE, CA, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has...
Cannabis Science Actively Pursuing U.S. Federal Government Contracts and Is Preparing Applications for Submission While Confirming the CBIS Security Team (CBISST) is Ready for Action
January 09, 2018 12:07 ET
|
Cannabis Science, Inc.
IRVINE, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that it has...
CBIS Reports on November 30, 2017 TRO Hearing and Next Steps; Hearing on a Preliminary Injunction Arguments Based on Information Disregarded by San Joaquin County
December 04, 2017 13:45 ET
|
Cannabis Science, Inc.
IRVINE, CA, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the...